Impact of a code stroke protocol on the door-to-needle time for IV thrombolysis: a feasibility study

Acta Clin Belg. 2020 Aug;75(4):267-274. doi: 10.1080/17843286.2019.1607991. Epub 2019 May 11.

Abstract

Introduction: Stroke is a development of an acute focal neurological deficit with an ischemic or hemorrhagic origin. Thrombolysis within 4.5 h of ischemic stroke onset improves outcome. Guidelines recommend administration of intravenous recombinant tissue plasminogen activator within 60 min upon arrival at the hospital, meaning the door-to-needle time (DNT) should be less than 60 min. In this study, a stroke protocol was introduced at the emergency department of the Ghent University Hospital with a primary goal to shorten the DNT.

Methodology: This study was an uncontrolled before-after cohort study. A 'Code Stroke' protocol (CSP) was implemented and the results from the pre-code stroke protocol period (Pre-CSP period, from 15 August 2016 until 5 March 2017) were compared with the results from the post-code stroke protocol period (Post-CSP period, from 6 March 2017 until 16 July 2017).

Results: The median DNT decreased significantly from 57 min in the Pre-CSP period to 33 min in the Post-CSP period (p < 0.001). The door-to-triage time (DTT), triage-to-emergency physician time (TET), emergency physician-to-CT time (ECT) and CT-to needle time (CNT) decreased significantly Post-CSP compared to Pre-CSP. When adjusting the results for other variables that might have an influence on these time intervals, the TET, ECT and CNT also decreased significantly. There was a statistically significant effect of the implementation of the CSP on the number of patients treated with a DNT within 20, 30, 45 and 60 min (p = 0.008).

Conclusion: A significant decrease in DNT can be achieved with the implementation of this stroke protocol.

Keywords: Stroke; door-to-needle time; emergency department; protocol; thrombolysis.

MeSH terms

  • Administration, Intravenous
  • Aged
  • Aged, 80 and over
  • Computed Tomography Angiography
  • Emergency Medicine
  • Emergency Nursing
  • Emergency Service, Hospital / organization & administration
  • Feasibility Studies
  • Female
  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • Ischemic Stroke / diagnostic imaging
  • Ischemic Stroke / drug therapy*
  • Male
  • Middle Aged
  • Neurologists
  • Patient Care Team / organization & administration
  • Perfusion Imaging
  • Radiologists
  • Thrombolytic Therapy / statistics & numerical data*
  • Time-to-Treatment / statistics & numerical data*
  • Tissue Plasminogen Activator / therapeutic use*
  • Tomography, X-Ray Computed
  • Triage / organization & administration

Substances

  • Fibrinolytic Agents
  • Tissue Plasminogen Activator